The global Drug-Eluting Balloon Catheters market was valued at US$ 1520 million in 2025 and is anticipated to reach US$ 3511 million by 2032, at a CAGR of 12.6% from 2026 to 2032.

Drug-Eluting Balloon Catheters Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Drug-Eluting Balloon Catheters competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Drug-eluting balloon catheters (often referred to as drug-coated balloon catheters, DCB) are endovascular angioplasty balloons coated with an antiproliferative drug plus an excipient/carrier system. During angioplasty, they deliver mechanical lumen gain while rapidly transferring drug into the vessel wall to inhibit neointimal hyperplasia and reduce restenosis and repeat interventions. The strategic concept is “leave nothing behind,” avoiding the long-term burden of permanent implants and enabling flexible future treatment options, increasingly integrated with lesion-preparation tools and intravascular imaging to support more refined vascular repair.In 2025, global Drug-eluting balloon catheters production reached approximately1528 k units and price is 995 USD/Unit.The average gross profit margin of this product is 73%.

Growth is driven by two structural forces: a shift from implant-centric to repair-centric care, where DCBs address restenosis and reintervention pain points with a “leave nothing behind” proposition; and a clearer evidence/regulatory boundary that improves hospital-level adoption confidence. The FDA’s updated assessment on paclitaxel-coated devices for PAD strengthens predictability around long-term safety considerations. Meanwhile, leading medtech companies continue to position DCB portfolios as a contributor to peripheral/vascular growth in annual reporting, signaling an evolution from an adjunct option toward a more standardized toolset.

The hurdle is scaling with reproducibility and compliance. As drug-device combination products, DCBs are highly sensitive to coating integrity, particulate control, dose consistency, and stability—where process drift can translate into outsized clinical and access risk. In parallel, cost containment and procurement reforms elevate quality systems, supply assurance, and cost efficiency as decisive differentiators. In China, national-level centralized procurement and published outcomes accelerate a more rules-based, scale-driven competitive phase.

Demand is consolidating around repeatable techniques and bundled solutions. Hospitals increasingly prioritize lower repeat interventions, pathway efficiency, and stable long-term outcomes—driving more routine combination of DCBs with lesion preparation tools, specialty balloons, and intravascular imaging (IVUS/OCT). In peripheral and dialysis access settings where recurrence is common, the preference to avoid repeat implants and preserve future options further reinforces the “leave nothing behind” value narrative.

Upstream advantage is defined by integrated “materials-coating-validation” capability rather than a simple bill of materials. Key inputs include balloon/catheter polymers and reinforcements, drug APIs (paclitaxel or limus agents) and excipient systems, coating solvents and metrology consumables, lubricious/hydrophilic surface coatings, plus sterile barrier packaging and sterilization services. Because requirements on biocompatibility and change control are stringent, medical-grade traceability, clean manufacturing, and robust change management at the supplier level directly shape yield, release consistency, and global compliance efficiency for OEMs.

This report delivers a comprehensive overview of the global Drug-Eluting Balloon Catheters market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Drug-Eluting Balloon Catheters. The Drug-Eluting Balloon Catheters market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Drug-Eluting Balloon Catheters market comprehensively. Regional market sizes by Type, by Application, by Use Scenario, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Drug-Eluting Balloon Catheters manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Drug-Eluting Balloon Catheters Market Report

Report Metric	Details
Report Name	Drug-Eluting Balloon Catheters Market
Accounted market size in 2025	US$ 1520 million
Forecasted market size in 2032	US$ 3511 million
CAGR	12.6%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Coronary Artery Disease Drug-Eluting Balloon Catheters Peripheral Vascular Disease Drug-Eluting Balloon Catheters
Segment by Use Scenario	In-Stent Restenosi De Novo Small Vessel
Segment by Balloon Platform Mechanics	Semi-/Compliant Non-compliant Other
by Application	Hospitals and Clinics Ambulatory Surgical Centers Catheterization Laboratories
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	B. Braun, Medtronic, Boston Scientific, BD, Yinyi Biotechnology, Acotec, Philips, Lepu Medical, Eurocor, MicroPort Medical, Teleflex
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Use Scenario, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Drug-Eluting Balloon Catheters manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Drug-Eluting Balloon Catheters sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Drug-Eluting Balloon Catheters Market growing?

Ans: The Drug-Eluting Balloon Catheters Market witnessing a CAGR of 12.6% during the forecast period 2026-2032.

What is the Drug-Eluting Balloon Catheters Market size in 2032?

Ans: The Drug-Eluting Balloon Catheters Market size in 2032 will be US$ 3511 million.

Who are the main players in the Drug-Eluting Balloon Catheters Market report?

Ans: The main players in the Drug-Eluting Balloon Catheters Market are B. Braun, Medtronic, Boston Scientific, BD, Yinyi Biotechnology, Acotec, Philips, Lepu Medical, Eurocor, MicroPort Medical, Teleflex

What are the Application segmentation covered in the Drug-Eluting Balloon Catheters Market report?

Ans: The Applications covered in the Drug-Eluting Balloon Catheters Market report are Hospitals and Clinics, Ambulatory Surgical Centers, Catheterization Laboratories

What are the Type segmentation covered in the Drug-Eluting Balloon Catheters Market report?

Ans: The Types covered in the Drug-Eluting Balloon Catheters Market report are Coronary Artery Disease Drug-Eluting Balloon Catheters, Peripheral Vascular Disease Drug-Eluting Balloon Catheters

1 Drug-Eluting Balloon Catheters Market Overview

1.1 Product Definition

1.2 Drug-Eluting Balloon Catheters by Type

1.2.1 Global Drug-Eluting Balloon Catheters Market Value by Type: 2025 vs 2032

1.2.2 Coronary Artery Disease Drug-Eluting Balloon Catheters

1.2.3 Peripheral Vascular Disease Drug-Eluting Balloon Catheters

1.3 Drug-Eluting Balloon Catheters by Use Scenario

1.3.1 Global Drug-Eluting Balloon Catheters Market Value by Use Scenario: 2025 vs 2032

1.3.2 In-Stent Restenosi

1.3.3 De Novo

1.3.4 Small Vessel

1.4 Drug-Eluting Balloon Catheters by Balloon Platform Mechanics

1.4.1 Global Drug-Eluting Balloon Catheters Market Value by Balloon Platform Mechanics: 2025 vs 2032

1.4.2 Semi-/Compliant

1.4.3 Non-compliant

1.4.4 Other

1.5 Drug-Eluting Balloon Catheters by Application

1.5.1 Global Drug-Eluting Balloon Catheters Market Value by Application: 2025 vs 2032

1.5.2 Hospitals and Clinics

1.5.3 Ambulatory Surgical Centers

1.5.4 Catheterization Laboratories

1.6 Global Drug-Eluting Balloon Catheters Market Size Estimates and Forecasts

1.6.1 Global Drug-Eluting Balloon Catheters Revenue 2021–2032

1.6.2 Global Drug-Eluting Balloon Catheters Sales 2021–2032

1.6.3 Global Drug-Eluting Balloon Catheters Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2 Drug-Eluting Balloon Catheters Market Competition by Manufacturers

2.1 Global Drug-Eluting Balloon Catheters Sales Market Share by Manufacturers (2021–2026)

2.2 Global Drug-Eluting Balloon Catheters Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Drug-Eluting Balloon Catheters Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Drug-Eluting Balloon Catheters, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Drug-Eluting Balloon Catheters, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Drug-Eluting Balloon Catheters, Product Types and Applications

2.7 Global Key Manufacturers of Drug-Eluting Balloon Catheters, Date of Entry into the Industry

2.8 Global Drug-Eluting Balloon Catheters Market Competitive Situation and Trends

2.8.1 Global Drug-Eluting Balloon Catheters Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Drug-Eluting Balloon Catheters Players Market Share by Revenue

2.8.3 Global Drug-Eluting Balloon Catheters Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Drug-Eluting Balloon Catheters Market Scenario by Region

3.1 Global Drug-Eluting Balloon Catheters Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Drug-Eluting Balloon Catheters Sales by Region: 2021–2032

3.2.1 Global Drug-Eluting Balloon Catheters Sales by Region: 2021–2026

3.2.2 Global Drug-Eluting Balloon Catheters Sales by Region: 2027–2032

3.3 Global Drug-Eluting Balloon Catheters Revenue by Region: 2021–2032

3.3.1 Global Drug-Eluting Balloon Catheters Revenue by Region: 2021–2026

3.3.2 Global Drug-Eluting Balloon Catheters Revenue by Region: 2027–2032

3.4 North America Drug-Eluting Balloon Catheters Market Facts & Figures by Country

3.4.1 North America Drug-Eluting Balloon Catheters Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Drug-Eluting Balloon Catheters Sales by Country (2021–2032)

3.4.3 North America Drug-Eluting Balloon Catheters Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Drug-Eluting Balloon Catheters Market Facts & Figures by Country

3.5.1 Europe Drug-Eluting Balloon Catheters Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Drug-Eluting Balloon Catheters Sales by Country (2021–2032)

3.5.3 Europe Drug-Eluting Balloon Catheters Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Drug-Eluting Balloon Catheters Market Facts & Figures by Region

3.6.1 Asia Pacific Drug-Eluting Balloon Catheters Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Drug-Eluting Balloon Catheters Sales by Region (2021–2032)

3.6.3 Asia Pacific Drug-Eluting Balloon Catheters Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Drug-Eluting Balloon Catheters Market Facts & Figures by Country

3.7.1 Latin America Drug-Eluting Balloon Catheters Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Drug-Eluting Balloon Catheters Sales by Country (2021–2032)

3.7.3 Latin America Drug-Eluting Balloon Catheters Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Drug-Eluting Balloon Catheters Market Facts & Figures by Country

3.8.1 Middle East and Africa Drug-Eluting Balloon Catheters Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Drug-Eluting Balloon Catheters Sales by Country (2021–2032)

3.8.3 Middle East and Africa Drug-Eluting Balloon Catheters Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Drug-Eluting Balloon Catheters Sales by Type (2021–2032)

4.1.1 Global Drug-Eluting Balloon Catheters Sales by Type (2021–2026)

4.1.2 Global Drug-Eluting Balloon Catheters Sales by Type (2027–2032)

4.1.3 Global Drug-Eluting Balloon Catheters Sales Market Share by Type (2021–2032)

4.2 Global Drug-Eluting Balloon Catheters Revenue by Type (2021–2032)

4.2.1 Global Drug-Eluting Balloon Catheters Revenue by Type (2021–2026)

4.2.2 Global Drug-Eluting Balloon Catheters Revenue by Type (2027–2032)

4.2.3 Global Drug-Eluting Balloon Catheters Revenue Market Share by Type (2021–2032)

4.3 Global Drug-Eluting Balloon Catheters Price by Type (2021–2032)

5 Segment by Application

5.1 Global Drug-Eluting Balloon Catheters Sales by Application (2021–2032)

5.1.1 Global Drug-Eluting Balloon Catheters Sales by Application (2021–2026)

5.1.2 Global Drug-Eluting Balloon Catheters Sales by Application (2027–2032)

5.1.3 Global Drug-Eluting Balloon Catheters Sales Market Share by Application (2021–2032)

5.2 Global Drug-Eluting Balloon Catheters Revenue by Application (2021–2032)

5.2.1 Global Drug-Eluting Balloon Catheters Revenue by Application (2021–2026)

5.2.2 Global Drug-Eluting Balloon Catheters Revenue by Application (2027–2032)

5.2.3 Global Drug-Eluting Balloon Catheters Revenue Market Share by Application (2021–2032)

5.3 Global Drug-Eluting Balloon Catheters Price by Application (2021–2032)

6 Key Companies Profiled

6.1 B. Braun

6.1.1 B. Braun Company Information

6.1.2 B. Braun Description and Business Overview

6.1.3 B. Braun Drug-Eluting Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 B. Braun Drug-Eluting Balloon Catheters Product Portfolio

6.1.5 B. Braun Recent Developments/Updates

6.2 Medtronic

6.2.1 Medtronic Company Information

6.2.2 Medtronic Description and Business Overview

6.2.3 Medtronic Drug-Eluting Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Medtronic Drug-Eluting Balloon Catheters Product Portfolio

6.2.5 Medtronic Recent Developments/Updates

6.3 Boston Scientific

6.3.1 Boston Scientific Company Information

6.3.2 Boston Scientific Description and Business Overview

6.3.3 Boston Scientific Drug-Eluting Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Boston Scientific Drug-Eluting Balloon Catheters Product Portfolio

6.3.5 Boston Scientific Recent Developments/Updates

6.4 BD

6.4.1 BD Company Information

6.4.2 BD Description and Business Overview

6.4.3 BD Drug-Eluting Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 BD Drug-Eluting Balloon Catheters Product Portfolio

6.4.5 BD Recent Developments/Updates

6.5 Yinyi Biotechnology

6.5.1 Yinyi Biotechnology Company Information

6.5.2 Yinyi Biotechnology Description and Business Overview

6.5.3 Yinyi Biotechnology Drug-Eluting Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Yinyi Biotechnology Drug-Eluting Balloon Catheters Product Portfolio

6.5.5 Yinyi Biotechnology Recent Developments/Updates

6.6 Acotec

6.6.1 Acotec Company Information

6.6.2 Acotec Description and Business Overview

6.6.3 Acotec Drug-Eluting Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Acotec Drug-Eluting Balloon Catheters Product Portfolio

6.6.5 Acotec Recent Developments/Updates

6.7 Philips

6.7.1 Philips Company Information

6.7.2 Philips Description and Business Overview

6.7.3 Philips Drug-Eluting Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Philips Drug-Eluting Balloon Catheters Product Portfolio

6.7.5 Philips Recent Developments/Updates

6.8 Lepu Medical

6.8.1 Lepu Medical Company Information

6.8.2 Lepu Medical Description and Business Overview

6.8.3 Lepu Medical Drug-Eluting Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Lepu Medical Drug-Eluting Balloon Catheters Product Portfolio

6.8.5 Lepu Medical Recent Developments/Updates

6.9 Eurocor

6.9.1 Eurocor Company Information

6.9.2 Eurocor Description and Business Overview

6.9.3 Eurocor Drug-Eluting Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Eurocor Drug-Eluting Balloon Catheters Product Portfolio

6.9.5 Eurocor Recent Developments/Updates

6.10 MicroPort Medical

6.10.1 MicroPort Medical Company Information

6.10.2 MicroPort Medical Description and Business Overview

6.10.3 MicroPort Medical Drug-Eluting Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 MicroPort Medical Drug-Eluting Balloon Catheters Product Portfolio

6.10.5 MicroPort Medical Recent Developments/Updates

6.11 Teleflex

6.11.1 Teleflex Company Information

6.11.2 Teleflex Description and Business Overview

6.11.3 Teleflex Drug-Eluting Balloon Catheters Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Teleflex Drug-Eluting Balloon Catheters Product Portfolio

6.11.5 Teleflex Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Drug-Eluting Balloon Catheters Industry Chain Analysis

7.2 Drug-Eluting Balloon Catheters Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Drug-Eluting Balloon Catheters Production Mode & Process Analysis

7.4 Drug-Eluting Balloon Catheters Sales and Marketing

7.4.1 Drug-Eluting Balloon Catheters Sales Channels

7.4.2 Drug-Eluting Balloon Catheters Distributors

7.5 Drug-Eluting Balloon Catheters Customer Analysis

8 Drug-Eluting Balloon Catheters Market Dynamics

8.1 Drug-Eluting Balloon Catheters Industry Trends

8.2 Drug-Eluting Balloon Catheters Market Drivers

8.3 Drug-Eluting Balloon Catheters Market Challenges

8.4 Drug-Eluting Balloon Catheters Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Biotronik ic

Eurocor GmbH

List of Tables

Table 1. Global Drug-Eluting Balloon Catheters Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Drug-Eluting Balloon Catheters Market Value by Use Scenario (US$ Million), 2025 vs 2032

Table 3. Global Drug-Eluting Balloon Catheters Market Value by Balloon Platform Mechanics (US$ Million), 2025 vs 2032

Table 4. Global Drug-Eluting Balloon Catheters Market Value by Application (US$ Million), 2025 vs 2032

Table 5. Global Drug-Eluting Balloon Catheters Market Competitive Situation by Manufacturers in 2025

Table 6. Global Drug-Eluting Balloon Catheters Sales (K Units) of Key Manufacturers (2021–2026)

Table 7. Global Drug-Eluting Balloon Catheters Sales Market Share by Manufacturers (2021–2026)

Table 8. Global Drug-Eluting Balloon Catheters Revenue (US$ Million) by Manufacturers (2021–2026)

Table 9. Global Drug-Eluting Balloon Catheters Revenue Share by Manufacturers (2021–2026)

Table 10. Global Market Drug-Eluting Balloon Catheters Average Price (US$/Unit) of Key Manufacturers (2021–2026)

Table 11. Global Key Players of Drug-Eluting Balloon Catheters, Industry Ranking, 2023 vs 2024 vs 2025

Table 12. Global Key Manufacturers of Drug-Eluting Balloon Catheters, Manufacturing Sites and Headquarters

Table 13. Global Key Manufacturers of Drug-Eluting Balloon Catheters, Product Types and Applications

Table 14. Global Key Manufacturers of Drug-Eluting Balloon Catheters, Date of Entry into the Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Drug-Eluting Balloon Catheters Companies by Tier (Tier 1, Tier 2, Tier 3), based on Drug-Eluting Balloon Catheters Revenue, 2025

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Drug-Eluting Balloon Catheters Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global Drug-Eluting Balloon Catheters Sales by Region (K Units), 2021–2026

Table 20. Global Drug-Eluting Balloon Catheters Sales Market Share by Region (2021–2026)

Table 21. Global Drug-Eluting Balloon Catheters Sales by Region (K Units), 2027–2032

Table 22. Global Drug-Eluting Balloon Catheters Sales Market Share by Region (2027–2032)

Table 23. Global Drug-Eluting Balloon Catheters Revenue by Region (US$ Million), 2021–2026

Table 24. Global Drug-Eluting Balloon Catheters Revenue Market Share by Region (2021–2026)

Table 25. Global Drug-Eluting Balloon Catheters Revenue by Region (US$ Million), 2027–2032

Table 26. Global Drug-Eluting Balloon Catheters Revenue Market Share by Region (2027–2032)

Table 27. North America Drug-Eluting Balloon Catheters Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 28. North America Drug-Eluting Balloon Catheters Sales by Country (K Units), 2021–2026

Table 29. North America Drug-Eluting Balloon Catheters Sales by Country (K Units), 2027–2032

Table 30. North America Drug-Eluting Balloon Catheters Revenue by Country (US$ Million), 2021–2026

Table 31. North America Drug-Eluting Balloon Catheters Revenue by Country (US$ Million), 2027–2032

Table 32. Europe Drug-Eluting Balloon Catheters Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 33. Europe Drug-Eluting Balloon Catheters Sales by Country (K Units), 2021–2026

Table 34. Europe Drug-Eluting Balloon Catheters Sales by Country (K Units), 2027–2032

Table 35. Europe Drug-Eluting Balloon Catheters Revenue by Country (US$ Million), 2021–2026

Table 36. Europe Drug-Eluting Balloon Catheters Revenue by Country (US$ Million), 2027–2032

Table 37. Asia Pacific Drug-Eluting Balloon Catheters Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 38. Asia Pacific Drug-Eluting Balloon Catheters Sales by Region (K Units), 2021–2026

Table 39. Asia Pacific Drug-Eluting Balloon Catheters Sales by Region (K Units), 2027–2032

Table 40. Asia Pacific Drug-Eluting Balloon Catheters Revenue by Region (US$ Million), 2021–2026

Table 41. Asia Pacific Drug-Eluting Balloon Catheters Revenue by Region (US$ Million), 2027–2032

Table 42. Latin America Drug-Eluting Balloon Catheters Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 43. Latin America Drug-Eluting Balloon Catheters Sales by Country (K Units), 2021–2026

Table 44. Latin America Drug-Eluting Balloon Catheters Sales by Country (K Units), 2027–2032

Table 45. Latin America Drug-Eluting Balloon Catheters Revenue by Country (US$ Million), 2021–2026

Table 46. Latin America Drug-Eluting Balloon Catheters Revenue by Country (US$ Million), 2027–2032

Table 47. Middle East and Africa Drug-Eluting Balloon Catheters Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 48. Middle East and Africa Drug-Eluting Balloon Catheters Sales by Country (K Units), 2021–2026

Table 49. Middle East and Africa Drug-Eluting Balloon Catheters Sales by Country (K Units), 2027–2032

Table 50. Middle East and Africa Drug-Eluting Balloon Catheters Revenue by Country (US$ Million), 2021–2026

Table 51. Middle East and Africa Drug-Eluting Balloon Catheters Revenue by Country (US$ Million), 2027–2032

Table 52. Global Drug-Eluting Balloon Catheters Sales (K Units) by Type (2021–2026)

Table 53. Global Drug-Eluting Balloon Catheters Sales (K Units) by Type (2027–2032)

Table 54. Global Drug-Eluting Balloon Catheters Sales Market Share by Type (2021–2026)

Table 55. Global Drug-Eluting Balloon Catheters Sales Market Share by Type (2027–2032)

Table 56. Global Drug-Eluting Balloon Catheters Revenue (US$ Million) by Type (2021–2026)

Table 57. Global Drug-Eluting Balloon Catheters Revenue (US$ Million) by Type (2027–2032)

Table 58. Global Drug-Eluting Balloon Catheters Revenue Market Share by Type (2021–2026)

Table 59. Global Drug-Eluting Balloon Catheters Revenue Market Share by Type (2027–2032)

Table 60. Global Drug-Eluting Balloon Catheters Price (US$/Unit) by Type (2021–2026)

Table 61. Global Drug-Eluting Balloon Catheters Price (US$/Unit) by Type (2027–2032)

Table 62. Global Drug-Eluting Balloon Catheters Sales (K Units) by Application (2021–2026)

Table 63. Global Drug-Eluting Balloon Catheters Sales (K Units) by Application (2027–2032)

Table 64. Global Drug-Eluting Balloon Catheters Sales Market Share by Application (2021–2026)

Table 65. Global Drug-Eluting Balloon Catheters Sales Market Share by Application (2027–2032)

Table 66. Global Drug-Eluting Balloon Catheters Revenue (US$ Million) by Application (2021–2026)

Table 67. Global Drug-Eluting Balloon Catheters Revenue (US$ Million) by Application (2027–2032)

Table 68. Global Drug-Eluting Balloon Catheters Revenue Market Share by Application (2021–2026)

Table 69. Global Drug-Eluting Balloon Catheters Revenue Market Share by Application (2027–2032)

Table 70. Global Drug-Eluting Balloon Catheters Price (US$/Unit) by Application (2021–2026)

Table 71. Global Drug-Eluting Balloon Catheters Price (US$/Unit) by Application (2027–2032)

Table 72. B. Braun Company Information

Table 73. B. Braun Description and Business Overview

Table 74. B. Braun Drug-Eluting Balloon Catheters Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 75. B. Braun Drug-Eluting Balloon Catheters Product

Table 76. B. Braun Recent Developments/Updates

Table 77. Medtronic Company Information

Table 78. Medtronic Description and Business Overview

Table 79. Medtronic Drug-Eluting Balloon Catheters Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 80. Medtronic Drug-Eluting Balloon Catheters Product

Table 81. Medtronic Recent Developments/Updates

Table 82. Boston Scientific Company Information

Table 83. Boston Scientific Description and Business Overview

Table 84. Boston Scientific Drug-Eluting Balloon Catheters Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 85. Boston Scientific Drug-Eluting Balloon Catheters Product

Table 86. Boston Scientific Recent Developments/Updates

Table 87. BD Company Information

Table 88. BD Description and Business Overview

Table 89. BD Drug-Eluting Balloon Catheters Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 90. BD Drug-Eluting Balloon Catheters Product

Table 91. BD Recent Developments/Updates

Table 92. Yinyi Biotechnology Company Information

Table 93. Yinyi Biotechnology Description and Business Overview

Table 94. Yinyi Biotechnology Drug-Eluting Balloon Catheters Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 95. Yinyi Biotechnology Drug-Eluting Balloon Catheters Product

Table 96. Yinyi Biotechnology Recent Developments/Updates

Table 97. Acotec Company Information

Table 98. Acotec Description and Business Overview

Table 99. Acotec Drug-Eluting Balloon Catheters Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 100. Acotec Drug-Eluting Balloon Catheters Product

Table 101. Acotec Recent Developments/Updates

Table 102. Philips Company Information

Table 103. Philips Description and Business Overview

Table 104. Philips Drug-Eluting Balloon Catheters Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 105. Philips Drug-Eluting Balloon Catheters Product

Table 106. Philips Recent Developments/Updates

Table 107. Lepu Medical Company Information

Table 108. Lepu Medical Description and Business Overview

Table 109. Lepu Medical Drug-Eluting Balloon Catheters Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 110. Lepu Medical Drug-Eluting Balloon Catheters Product

Table 111. Lepu Medical Recent Developments/Updates

Table 112. Eurocor Company Information

Table 113. Eurocor Description and Business Overview

Table 114. Eurocor Drug-Eluting Balloon Catheters Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 115. Eurocor Drug-Eluting Balloon Catheters Product

Table 116. Eurocor Recent Developments/Updates

Table 117. MicroPort Medical Company Information

Table 118. MicroPort Medical Description and Business Overview

Table 119. MicroPort Medical Drug-Eluting Balloon Catheters Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 120. MicroPort Medical Drug-Eluting Balloon Catheters Product

Table 121. MicroPort Medical Recent Developments/Updates

Table 122. Teleflex Company Information

Table 123. Teleflex Description and Business Overview

Table 124. Teleflex Drug-Eluting Balloon Catheters Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

Table 125. Teleflex Drug-Eluting Balloon Catheters Product

Table 126. Teleflex Recent Developments/Updates

Table 127. Key Raw Materials Lists

Table 128. Raw Materials Key Suppliers Lists

Table 129. Drug-Eluting Balloon Catheters Distributors List

Table 130. Drug-Eluting Balloon Catheters Customers List

Table 131. Drug-Eluting Balloon Catheters Market Trends

Table 132. Drug-Eluting Balloon Catheters Market Drivers

Table 133. Drug-Eluting Balloon Catheters Market Challenges

Table 134. Drug-Eluting Balloon Catheters Market Restraints

Table 135. Research Programs/Design for This Report

Table 136. Key Data Information from Secondary Sources

Table 137. Key Data Information from Primary Sources

Table 138. Authors List of This Report

List of Figures

Figure 1. Product Picture of Drug-Eluting Balloon Catheters

Figure 2. Global Drug-Eluting Balloon Catheters Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Drug-Eluting Balloon Catheters Market Share by Type: 2025 & 2032

Figure 4. Coronary Artery Disease Drug-Eluting Balloon Catheters Product Picture

Figure 5. Peripheral Vascular Disease Drug-Eluting Balloon Catheters Product Picture

Figure 6. Global Drug-Eluting Balloon Catheters Market Value by Use Scenario (US$ Million), 2021–2032

Figure 7. Global Drug-Eluting Balloon Catheters Market Share by Use Scenario: 2025 vs 2032

Figure 8. In-Stent Restenosi Product Picture

Figure 9. De Novo Product Picture

Figure 10. Small Vessel Product Picture

Figure 11. Global Drug-Eluting Balloon Catheters Market Value by Balloon Platform Mechanics (US$ Million), 2021–2032

Figure 12. Global Drug-Eluting Balloon Catheters Market Share by Balloon Platform Mechanics: 2025 vs 2032

Figure 13. Semi-/Compliant Product Picture

Figure 14. Non-compliant Product Picture

Figure 15. Other Product Picture

Figure 16. Global Drug-Eluting Balloon Catheters Market Value by Application (US$ Million), 2021–2032

Figure 17. Global Drug-Eluting Balloon Catheters Market Share by Application: 2025 & 2032

Figure 18. Hospitals and Clinics

Figure 19. Ambulatory Surgical Centers

Figure 20. Catheterization Laboratories

Figure 21. Global Drug-Eluting Balloon Catheters Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 22. Global Drug-Eluting Balloon Catheters Market Size (US$ Million), 2021–2032

Figure 23. Global Drug-Eluting Balloon Catheters Sales (K Units), 2021–2032

Figure 24. Global Drug-Eluting Balloon Catheters Average Price (US$/Unit), 2021–2032

Figure 25. Drug-Eluting Balloon Catheters Report Years Considered

Figure 26. Drug-Eluting Balloon Catheters Sales Share by Manufacturers in 2025

Figure 27. Global Drug-Eluting Balloon Catheters Revenue Share by Manufacturers in 2025

Figure 28. Top 5 and Top 10 Global Drug-Eluting Balloon Catheters Players: Market Share by Revenue in Drug-Eluting Balloon Catheters in 2025

Figure 29. Drug-Eluting Balloon Catheters Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 30. Global Drug-Eluting Balloon Catheters Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 31. North America Drug-Eluting Balloon Catheters Sales Market Share by Country (2021–2032)

Figure 32. North America Drug-Eluting Balloon Catheters Revenue Market Share by Country (2021–2032)

Figure 33. United States Drug-Eluting Balloon Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 34. Canada Drug-Eluting Balloon Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 35. Europe Drug-Eluting Balloon Catheters Sales Market Share by Country (2021–2032)

Figure 36. Europe Drug-Eluting Balloon Catheters Revenue Market Share by Country (2021–2032)

Figure 37. Germany Drug-Eluting Balloon Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. France Drug-Eluting Balloon Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. U.K. Drug-Eluting Balloon Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 40. Italy Drug-Eluting Balloon Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 41. Russia Drug-Eluting Balloon Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. Asia Pacific Drug-Eluting Balloon Catheters Sales Market Share by Region (2021–2032)

Figure 43. Asia Pacific Drug-Eluting Balloon Catheters Revenue Market Share by Region (2021–2032)

Figure 44. China Drug-Eluting Balloon Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Japan Drug-Eluting Balloon Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. South Korea Drug-Eluting Balloon Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 47. India Drug-Eluting Balloon Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 48. Australia Drug-Eluting Balloon Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. China Taiwan Drug-Eluting Balloon Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. Southeast Asia Drug-Eluting Balloon Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. Latin America Drug-Eluting Balloon Catheters Sales Market Share by Country (2021–2032)

Figure 52. Latin America Drug-Eluting Balloon Catheters Revenue Market Share by Country (2021–2032)

Figure 53. Mexico Drug-Eluting Balloon Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Brazil Drug-Eluting Balloon Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. Argentina Drug-Eluting Balloon Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 56. Middle East and Africa Drug-Eluting Balloon Catheters Sales Market Share by Country (2021–2032)

Figure 57. Middle East and Africa Drug-Eluting Balloon Catheters Revenue Market Share by Country (2021–2032)

Figure 58. Turkey Drug-Eluting Balloon Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 59. Saudi Arabia Drug-Eluting Balloon Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 60. UAE Drug-Eluting Balloon Catheters Revenue Growth Rate (US$ Million), 2021–2032

Figure 61. Global Sales Market Share of Drug-Eluting Balloon Catheters by Type (2021–2032)

Figure 62. Global Revenue Market Share of Drug-Eluting Balloon Catheters by Type (2021–2032)

Figure 63. Global Drug-Eluting Balloon Catheters Price (US$/Unit) by Type (2021–2032)

Figure 64. Global Sales Market Share of Drug-Eluting Balloon Catheters by Application (2021–2032)

Figure 65. Global Revenue Market Share of Drug-Eluting Balloon Catheters by Application (2021–2032)

Figure 66. Global Drug-Eluting Balloon Catheters Price (US$/Unit) by Application (2021–2032)

Figure 67. Drug-Eluting Balloon Catheters Value Chain

Figure 68. Channels of Distribution (Direct Vs Distribution)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Balloon Catheter Market Research Report 2024

Global Balloon Catheters Market Research Report 2025

Global Drug Balloon Dilatation Catheter Market Research Report 2024

Global Medical Balloon Catheter Market Research Report 2024

Drug Coated Balloon Catheter Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Balloon Angioplasty and Heart Stents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drug Coated PTA Balloon Catheter Market Research Report 2024

Drug Eluting Catheter Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Advanced Balloon Catheter Market Research Report 2024

Global Occlusion Balloon Catheter Market Research Report 2025

Medical Micro balloon Catheter Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Balloon Dilation Catheter Market Research Report 2024

Global Dual Balloon Angioplasty Catheter Market Research Report 2025

Global Peripheral Drug eluting Balloon Market Research Report 2025

Global Nosebleed Balloon Catheters Market Research Report 2024

Global Percutaneous Coronary Intervention Balloon Catheter Market Insights Forecast to 2030

Global Delivery Balloon Dilatation Catheter Market Research Report 2024

Global Sterile Balloon Catheter Market Research Report 2025

Percutaneous Transluminal Angioplasty Balloon Catheter PTA Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions